Maan Pharmaceuticals

Ahmedabad, India
Pharmaceutical company specializing in de-addiction treatments and global operations.
Annual revenue $12.4M Latest available
Total funding - Funding intelligence
Employees 27 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Maan Pharmaceuticals

Maan Pharmaceuticals is a company based in Ahmedabad (India). The company has 27 employees as of February 26, 2025. Maan Pharmaceuticals offers products and services including Buprenorphine Formulations and Naltrexone Formulations.

  • Headquarter Ahmedabad, India
  • Employees 27 as on 26 Feb, 2025
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Maan Pharmaceuticals Ltd
  • Date of Incorporation 13 May, 1988
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $12.45 M (USD)
    31.01
    as on Mar 31, 2024
  • Net Profit
    $1.71 M (USD)
    79.7
    as on Mar 31, 2024
  • EBITDA
    $2.67 M (USD)
    53.86
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    27

    as on Feb 26, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Maan Pharmaceuticals

Maan Pharmaceuticals offers a comprehensive portfolio of products and services, including Buprenorphine Formulations and Naltrexone Formulations.

Product name locked
Category locked
Primary

Formulations for substance abuse are developed and offered in various forms.

Product name locked
Category locked
Locked

Formulations addressing de-addiction needs are provided in branded and generic options.

Funding Insights of Maan Pharmaceuticals

Premium access

Detailed funding history for Maan Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Maan Pharmaceuticals

Investments
Premium access

Investment portfolio details for Maan Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Maan Pharmaceuticals

Premium access

Detailed financials for Maan Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Maan Pharmaceuticals Comparisons

Maan Pharmaceuticals Primary company
Description
Pharmaceutical company specializing in de-addiction treatmen...
Location
Ahmedabad, India
Founded Year
-
Annual Revenue
$12.45 M (USD)
Net Profit
$1.71 M (USD)
EBITDA
$2.67 M (USD)
Employees
27
As of 2025
Premium access

Peer comparison for Maan Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Maan Pharmaceuticals

Premium access

Detailed competitors of Maan Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Maan Pharmaceuticals

Premium access

Complete news archive for Maan Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maan Pharmaceuticals

Maan Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

As of Feb 26, 2025, the latest employee count at Maan Pharmaceuticals is 27.

Annual revenue of Maan Pharmaceuticals is $12.45M as on Mar 31, 2024.

MAAN Pharmaceuticals Ltd. is recognized as a global pharmaceutical entity that operates across more than 30 markets. It is dedicated to addressing substance abuse through the development of formulations for de-addiction treatments. Innovative technology is utilized to create superior quality products at affordable prices, with a strong emphasis on unmet medical needs. Manufacturing facilities in Mehsana, Gujarat, adhere to WHO-GMP standards and produce various dosage forms. The companys presence is established in the Indian subcontinent and is expanding internationally, focusing on improving patients quality of life.

Maan Pharmaceuticals offers Buprenorphine Formulations and Naltrexone Formulations.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available